ASX Share rice
Sat 15 Aug 2020 - 02:39:am (Sydney)

NTI Share Price

NEUROTECH INTERNATIONAL LIMITEDNTIHealth Care Equipment & Services

NTI Company Information

Name:

Neurotech International Limited

Sector:

Healthcare

Industry:

Medical Devices

GIC Industry:

Health Care Equipment & Supplies

GIC Sub Industry:

Health Care Equipment

Address:

145 Stirling Highway Nedlands WA Australia 6009

Phone:

61 8 9389 3130

Deputy Chairman, CEO & MD:

Mr. Peter James Lawrence Griffiths B.Sc.

Chief Scientific Officer & Member of Scientific Advisory Board:

Dr. Emanuela Russo

Company Sec.:

Ms. Erlyn Saromines Dale A.C.I.S., B.Com., BCom., GradDipACG, AGIA, ACIS

Company Overview:

Neurotech International Limited engages in the research, design, development, and manufacture of medical devices and solutions in Australia. Its product, Mente Autism, is a portable electroencephalogram medical device that uses neurofeedback to help relax the minds of children with autism spectrum disorder. The company focuses on developing neuro-stimulation and neuro-diagnostic solutions that enable medical practitioners to monitor and play an active role in home-based therapies. It also engages in executing medical research projects and developing technological devices; and publishing, registering, and maintaining intellectual property. The company was incorporated in 2016 and is based in Nedlands, Australia.

NTI Share Price Information

Shares Issued:

139.73M

Market Capitalisation:

$1.40M

Revenue (TTM):

$87.23K

Revenue Per Share (TTM):

$0

Earnings per Share:

$-0.041

Operating Margin (TTM):

$-20.74

Return On Assets (TTM):

$-0.71

Return On Equity (TTM):

$-3.46

Quarterly Revenue Growth (YOY):

-0.799

Gross Profit(TTM):

$-203,674

Diluted Earnings Per Share (TTM):

$-0.029

NTI CashFlow Statement

CashFlow Date:

2019-06-30

Change To Liabilities:

$-116,612

Net Borrowings:

$96.29K

Net Income:

$-4,802,208

Total Cash From Operating Activities:

$-2,543,052

Depreciation:

$2.02K

Change To Inventory:

$70.98K

Change To Account Receivables:

$130.11K

Sale Purchase Of Stock:

$-74,979

Capital Expenditures:

$0

NTI Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-4,802,208

Net Income:

$-4,802,208

Gross Profit:

$-251,962

Operating Income:

$-2,844,174

Other Operating Expenses:

$184.49K

Interest Expense:

$2.01K

Total Revenue:

$197.55K

Total Operating Expenses:

$2.59M

Cost Of Revenue:

$449.51K

NTI Balance Sheet

Balance Sheet Date:

2019-06-30

Total Liabilities:

$355.34K

Total Stockholder Equity:

$297.41K

Total Assets:

$652.75K

Common Stock:

$15.10M

Other Current Assets:

$28.84K

Retained Earnings:

$-16,181,019

Cash:

$474.68K

Total Current Liabilities:

$355.34K

Short-Term Debt:

$126.08K

Net Tangible Assets:

$297.41K

Total Current Assets:

$652.75K

Net Receivables:

$82.56K

Short-Term Investments:

$0

Inventory:

$0

Accounts Payable:

$154.22K

Non Currrent Assets (Other):

$0

Short-Term Investments:

$0

Non Current Liabilities Total:

$0

NTI Share Price History

NTI News

31 Mar, 2020
Every investor on earth makes bad calls sometimes. But you want to avoid the really big losses like the plague. So...
03 Oct, 2019
The big shareholder groups in Neurotech International Limited (ASX:NTI) have power over the company. Generally...